| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.75 | 0.003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.004 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |